Trial intelligence / Profile preview

MN-221 in acute exacerbation of asthma

NCT00838591Phase 2Completed

Sponsor
MediciNova, Inc.
Start
Mar 2009
Primary completion
Mar 2012
Countries
1
01

Overview

A Phase 2 trial of bedoradrine in asthma, sponsored by MediciNova, Inc.. Started Mar 2009; status: completed.

02

Drugs

bedoradrine
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00838591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00838591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call